The changes in serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FHS), estradiol, and progesterone that occur both early and late in reproductive life were characterized and compared with findings in young, normal women and in patients with certain menstrual disorders. A total of 50 complete menstrual cycles in 37 were examined. Five distinct patterns of hormonal regulation were found, three of which are reported here: (a) A long follicular phase and delayed follicular maturation in young women with long, unpredictable intermenstrual intervals from menarche; (b) a short follicular phase with increasing age and in short cycles in perimenopausal women; and (c) true anovulatory vaginal bleeding in long cycles in perimenopausal women. The short cycles before and during the menopausal transition were found to have lower E2 levels and high FSH concentrations throughout, while LH remained in the normal range. During long cycles in perimenopausal women, concentrations of LH and FSH were in the menopausal range. However, follicular maturation was observed months after high levels of gonadotropins were attained. These studies permit the characterization of the menstrual history of the normal woman in terms of the hormonal changes that occur and provide a basis for the definition of several disorders of follicular maturation. A total of 50 complete menstrual cycles in 37 women were examined. Five distinct patterns of hormonal regulation were found, three of which are reported here: (a) A long follicular phase and delayed follicular maturation in young women with long, unpredictable intermenstrual intervals from menarche; (b) a short follicular phase with increasing age and in short cycles in perimenopausal women; and (c) true anovulatory vaginal bleeding in long cycles in perimenopausal women.
INTRODUCTION
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lations studied prospectively, variability in cycle length has been shown during the years that immediately follow menarche and precede menopause (1) . The pattern of vaginal bleeding after menarche is often characterized by long intermenstrual intervals. Between the ages of 25 and 40, cycle length is regular, and there is a gradual decrease in total cycle length until the menopausal transition. Before menopause, the pattern of vaginal bleeding again becomes irregular, long intervals, often alternating with unusually short cycles (1) .
Analysis of hormonal regulation of the human menstrual cycle by measurement of circulating pituitary and ovarian hormones has, to date, been limited to young women with regular cycle (2) (3) (4) (5) (6) (7) (8) (9) (10) or to clinically abnormal cycles (11) (12) (13) (14) (15) (16) (17) . We have measured serum levels of serum luteinizing hormone (LH),1 folliclestimulating hormone (FSH), estradiol (E2), and progesterone (P), throughout the cycles of women at the extremes of menstrual experience and compared the findings with those in young and middle-aged normal women and in certain menstrual disorders previously reported (16, 17) .
Long cycles in young women of normal body weight were characterized by delayed follicular maturation and hormonal changes suggesting normal ovulation. In older women, decreased cycle length was due to a short follicular phase. In regularly menstruating premenopausal women there was hormonal evidence of follicular maturation and corpus luteum function with a significant decrease in length of the follicular phase, diminished E2 concentrations, and striking increases in the concentration of FSH throughout the cycle. During long cycles in perimenopausal women, levels of LH and FSH were in the menopausal range and vaginal bleeding occurred in the absence of follicular maturation 1 toms. Three were aware that cycle length had decreased in recent years. Four were parous, and two were nulliparous (4) . In one of these women, hormone analysis was carried out during the last 54 days of a subsequent cycle of more than 3 mo duration. Another woman, age 49, maintained a menstrual calendar from age 40. Long cycle intervals, unaccompanied by menopausal symptoms, began at age 48. Homone analysis was done during cycles of 63, 53, and 27 days.
Methods. Serum was stored at -200C, and each cycle was assayed as a unit so that fluctuations would represent intra-rather than interassay variation. The serum FSH and LH were measured by radioimmunoassay in a standard double-antibody system utilizing reagents supplied by the National Pituitary Agency (18, 19) . Results were expressed as nanograms per milliliter of the reference preparation LER 907. P and E2 were measured with antisera generously supplied by Dr. Gordon Niswender, and activated charcoal was used to separate bound from free steroid. The E2 method employed a specific antiserum and a simple ether extraction of serum (20) .
RESULTS
The values for LH, FSH, E2, and P in 10 women, age 18-30, shown in the shaded area of Figs. 1, 3, and 4, were not different from those described by others for women in this age group (2) (3) (4) (5) (6) (7) (8) (9) . In each instance FSH, AY. .F9QM Fig. 1 . In each case an indeterminately long follicular phase was followed by changes in hormone concentrations indicative of follicular maturation, ovulation, and corpus luteum function identical to those observed in the normal cycles. The increased cycle length was always due to a prolonged follicular phase of the cycle as measured by the time before the LH peak (Table I) . During the prolonged follicular phase, E2 levels were 70-110 pg/ml, LH and FSH were in the range observed during the normal follicular phase, and P was less than 1 ng/ml. In two of these cycles the maturation of a follicle was preceded by a rise of FSH comparable to that seen during the early follicular phase of many normal-length cycles. This increase in FSH occurred during days 20-25 of the cycle illustrated in Fig. 2 . The FSH rise was not sustained and, as in the normal group, fell slightly with follicular maturation.
In the women age 40-41, hormone values did not differ from those observed in the younger subjects (Fig. 3) . The decrease in mean cycle length (25.4 days) compared to the younger women (30.0 days) was attributable to a shorter interval between the onset of menses and the LH peak. The duration of time necessary for the follicle to complete its maturation, as characterized by the exponential rise in estradiol secretion, was no different in the two groups.
The six premenopausal women, age 46-51, had cycles shorter in total length (mean 23.3 days) than women 18-21 (Table I, Fig. 4 e.. 't contrast, the luteal phase, as measured from the LH peak to the onset of menses, was 10-16 (mean 13.0) (lays, and P levels were not different from those observed in younger women (Fig. 4) PAmEM less than 20 pg/ml to a maximum of 115 pg/ml at midcycle, while the P level rose from less than 1 ng/ml to 19 ng/ml during days [17] [18] [19] . LH concentrations were in the normal range throughout the cycle, while FSH remained elevated, with maximum levels of 1,500 ng/ml falling to a low of 200 ng/ml at the end of the luteal phase. Thus an anovulatory cycle was followed by a cycle that demonstrated evidence of follicular maturation. DISCUSSION These studies were based on the monumental prospective study of menstrual cycle length reported by Treloar, Boynton, Benn, and Brown, which showed that the 5-7 yr after menarche and 6-8 yr before menopause were characterized by wide variability in cycle length and contrasted with the years from 20 to 40, during which cycle length was regular and there was a gradual decrease of 2-3 days in mean cycle length (1). We have described the endocrinologic features of menstrual cycles at the extremes of reproductive life and compared them with cycles in regularly menstruating young women and with abnormal cycles recently reported.
Long cycles during the menarchial transition were characterized by delayed but completely normal follicular maturation, including basal body temperature records ( Figs. 1 and 2 , Table I ). Although the study of the menstrual cycles in the years immediately after menarche could not be done because of the necessity for frequent blood samples, the four young women reported here all had histories of irregular menses from the time of menarche.
In regularly menstruating women, age 40-41, the hormonal features of follicular maturation and corpus luteum function were not different from those of younger women (Fig. 3, Table I ). The slightly shorter Long cycles during menopausal transition.
cycle length was in all cases attributable to a reduced interval between the first day of menses and the midcycle gonadotropin peak. In contrast to the delayed follicular maturation in young women, regularly menstruating premenopausal women, age 46-51, often had short cycles also attributable in all cases to decreases in the time preceding hormonal evidence of follicular maturation. In these women, early follicular phase E2 levels were not different from those in younger women. The lower midcycle and luteal phase E2 concentrations must reflect decreased secretion by the maturing follicle and corpus luteum, since the metabolic clearance rate of E2 is not different in pre-and postmenopausal women (21) . This contrasts with corpus luteum P secretion, which was usually equal to that found in the younger women.
Long cycles during the menopausal transition women were terminated by an inadequate luteal phase or by an episode of vaginal bleeding that followed a simple decline in E2 concentration without hormonal evidence of ovulation or corpus luteum formation and in the presence of menopausal levels of gonadotropins, i.e., truly anovulatory cycles. The long cycles with high gonadotropin concentrations did not necessarily indicate the absence of follicles, because at least in one instance a short cycle demonstrating hormonal changes associated with follicular maturation and corpus luteum function followed long, anovulatory cycles (Fig. 6) .
We have recently reported a luteal phase of 10 days or less in four women who volunteered as normal subjects (16) . In two subjects a short luteal phase was found to occur repeatedly in four cycles analyzed over 1 yr. Luteal phase progesterone levels were uniformly low, the mean E2 peak was significantly below normal, and there was no E2 rise during the short luteal phase. FSH did not demonstrate the follicular phase increase observed during normal cycles and was significantly less than found in normal cycles during days -9 and -10.
Nine cycles of 24-157 days were studied in seven obese women, three of whom were hirsute (17) . All sought medical attention because of irregular menses. In each case menstruation was preceded by hormonal changes associated with follicular maturation and corpus luteum formation. Although in all nine cycles the luteal phase was of more than 10 days duration, P concentrations were uniformly low. The E2 peak and luteal phase E2 concentrations were not different from normal. However, as in short luteal phase cycles, FSH during follicular phase days -8 through -11 was significantly less than normal, while LH levels exhibited a normal pattern.
On the basis of these studies we propose a new classification for some clinical patterns of normal and abnormal vaginal bleeding (Table II) These data have led us to hypothesize an ovarian regulatory hormone, an inhibin, which would exert a negative feedback control over FSH secretion and which would be reduced in the years before menopause, consequent to a diminished number of follicles. We have not been able to find a previous reference to this possibilitv. There are several lines of evidence supporting the presence of an inhibin. First, during menopause, FSH and LH appear to change proportionally when estrogen is given (22) (23) (24) , and the two appear to rise proportionately after castration (25) (26) . A similar proportional fall in gonadotropins was noted with the spontaneous rise in E2 during the two anovulatory cycles of Fig. 6 . Therefore, a factor other than the concentration of E2 must be involved to produce the dissociation of FSH and LH levels seen in the older women. An important recent study has indicated that the presence or absence of ovarian follicles in women with primary or secondary amenorrhea can be predicted accurately by the level of FSH in the serum (27) . The absence of follicles resulted in a substantial increase in the FSH concentration regardless of the diagnosis. Although the exceedingly complex events controlling the concentration and changes in concentration of the two gonadotropins during the follicular phase of the normal menstrual cycle have been explained by differential effects of estrogen at the hypothalamus and pituitary (28) , the data are also compatible with the presence of another inhibitory regulator of FSH secretion that increases with follicular maturation.
Analogy with data in men provides additional support for the hypothesis. There are no sexually unique hormones, although there are wide variations in the secretion of hormones related to reproduction. Evidence for inhibin in the male is accumulating (29) (30) (31) (32) , and it has been invoked to account for high levels of FSH and normal levels of LH in oligospermic males (33) (34) (35) , after testicular irradiation and after cvtotoxic chemotherapy (36, 37) .
From the viewpoint of physiological need, an inhibin would be an important mechanism for controlling the number of follicles that mature each cycle and would be of special importance in higher species, where the number of conceptuses supportable during a gestation is limited. Finally, the presence of inhibin may aid our interpretation of certain disorders of reproductive function.
From longitudinal studies of the levels of FSH, LH, E2, and P during normal menstrual cycles throughout reproductive life and in association with certain types of clinical abnormalities, we have suggested a partial classification of menstrual cycle abnormalities (Table  II) and have hypothesized the presence of a hormonal control mechanism in women analogous to the inhibin proposed for men.
